1. Home
  2. Labeler Index
  3. Excella Gmbh & Co. Kg
  4. 46014-7300
  5. NDC Package Code: 46014-7300-4 Azacitidine

NDC Package 46014-7300-4 Azacitidine

Tablet, Film Coated - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
46014-7300-4
Package Description:
14 TABLET, FILM COATED in 1 BOTTLE
Product Code:
46014-7300
Non-Proprietary Name:
Azacitidine
Substance Name:
Azacitidine
Usage Information:
This medication is used to treat a group of blood/bone marrow disorders (myelodysplastic syndromes-MDS) in which the bone marrow does not produce enough healthy blood cells. People with MDS usually have problems such as infections, anemia, and easy bleeding/bruising. Azacitidine is believed to work by helping your bone marrow grow normal blood cells so you will need fewer blood transfusions. Azacitidine also kills abnormal blood cells that have grown too fast and do not work properly.
11-Digit NDC Billing Format:
46014730004
Product Type:
Human Prescription Drug
Labeler Name:
Excella Gmbh & Co. Kg
Dosage Form:
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Active Ingredient(s):
AZACITIDINE 300 mg/1
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
09-01-2020
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 46014-7300-4?

The NDC Packaged Code 46014-7300-4 is assigned to an UNFINISHED drug package of 14 tablet, film coated in 1 bottle of Azacitidine, a human prescription drug labeled by Excella Gmbh & Co. Kg. The product's dosage form is tablet, film coated and is administered via form.

Is NDC 46014-7300 included in the NDC Directory?

Yes, Azacitidine is an UNFINISHED PRODUCT with code 46014-7300 that is active and included in the NDC Directory. The product was first marketed by Excella Gmbh & Co. Kg on September 01, 2020 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 46014-7300-4?

The 11-digit format is 46014730004. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-146014-7300-45-4-246014-7300-04